From: Propylthiouracil (PTU) Hepatoxicity in Children and Recommendations for Discontinuation of Use
Authors, year | N | AE (n) | % AE | Adverse events |
---|---|---|---|---|
Hamburger, 1985 [57] | 182 | 31 | 17% | 11 Cutaneous |
1 Cutaneous and neutropenia | ||||
1 Cutaneous and rheumatological | ||||
1 Cutaneous and hepatic | ||||
1 Cutaneous and pharyngitis | ||||
4 Neutropenia | ||||
2 Hepatic | ||||
1 Rheumatological | ||||
2 Nausea | ||||
5 Multiple infections without neutropenia | ||||
1 Unspecified | ||||
Lippe et al., 1987 [59] | 63 | 1 | 1.5% | 1 Arthritic reaction |
Ward et al., 1999 [62] | 33 | 8 | 24% | Rash, arthralgia, nausea, vomiting |
Lazar et al., 2000 [63] | 28 | 14 | 35% | 2 Major; agranulocytosis; toxic hepatitis |
12 Minor | ||||
Somnuke et al., 2007 [61] | 32 | 2 | 6% | ANCA; nephritis |
Rash, arthralgia | ||||
Glaser and Styne, 2008 [56] | 70 | 11 | 16% | 1 Rash |
2 Rash and arthralgia | ||||
1 Arthritis with purpura | ||||
1 Arthritis with purpura, hematuria | ||||
3 Elevated liver function tests | ||||
2 Marked elevated liver function tests | ||||
2 Neutropenia | ||||
Ma et al., 2008 [60] | 40 | 8 | 20% | 6 Serious |
48 | 7 | 14.6% | NA |